Series date: 
01/01/2023 - 12:30pm to 12/31/2023 - 1:30pm

DESCRIPTION
This conference is designed to keep colleagues up-to-date on continuing advances in the field of Pulmonary, Allergy, and Sleep Medicine. Physicians need to discuss new methods of diagnosis and treatment, appreciate the development of new technology, receive input from experts regarding advances in medical knowledge, and share patient care experiences to learn from each other.

TARGET AUDIENCE
This course is intended primarily for physicians, fellows, allied health, NPs, and PAs from the fields of Pulmonary, Allergy, & Sleep Medicine

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

  • Review latest clinical practice guidelines and advances in research involving different diagnoses in the REM of Pulmonary Medicine, Allergy & Sleep Medicine.
  • Review the latest in clinical practice trends, monitoring of patient's satisfaction, quality and outcomes in the realms of Pulmonary, Allergy and Sleep Medicine. 

Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



Credit Statement(s):
AMA

Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Summary
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.

Listed below are individuals with control of the content of this program who have disclosed...

Relevant financial relationship(s) with ineligible companies:
Dr. Brendon Colaco - Consulting - Idorsia Pharmaceuticals, Aptus Health/Quantica MD, Elclvier, Mayo Global Health Solutions

All relevant financial relationships have been mitigated. 

No relevant financial relationship(s) with ineligible companies:
Dr. Augustine Lee
Jonathan Clark, RRT
Lisa Beagle, RRT
Maria I. Hemphill, RRT

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For additional disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee members visit ce.mayo.edu, About Us, Disclosures - or - https://ce.mayo.edu/content/disclosures

CE Broker Code: 23R00687-A

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows. 

COURSE DIRECTOR
Brendon Colaco, M.B.B.S.

QUESTIONS?
Contact Maria Hemphill or ph. 3-7070 

Support location: 
Florida